| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin A | 33 | 2016 | 87 | 3.510 |
Why?
|
| Retina | 26 | 2016 | 255 | 3.140 |
Why?
|
| Eye Proteins | 12 | 2018 | 46 | 3.040 |
Why?
|
| Pigment Epithelium of Eye | 25 | 2007 | 32 | 2.640 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2017 | 157 | 1.850 |
Why?
|
| Diabetic Retinopathy | 4 | 2018 | 65 | 1.650 |
Why?
|
| Retinal Cone Photoreceptor Cells | 5 | 2014 | 28 | 1.480 |
Why?
|
| Carboxylic Ester Hydrolases | 15 | 2003 | 46 | 1.480 |
Why?
|
| Transforming Growth Factor beta | 3 | 2016 | 183 | 1.370 |
Why?
|
| Transforming Growth Factor beta2 | 3 | 2016 | 8 | 1.330 |
Why?
|
| Retinoids | 10 | 2016 | 28 | 1.290 |
Why?
|
| Retinol-Binding Proteins | 4 | 2015 | 7 | 1.240 |
Why?
|
| Retinaldehyde | 8 | 2015 | 21 | 1.240 |
Why?
|
| Retinal Pigments | 17 | 2007 | 33 | 1.100 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2016 | 68 | 1.060 |
Why?
|
| Pericytes | 3 | 2017 | 21 | 1.050 |
Why?
|
| Chickens | 10 | 2012 | 123 | 1.040 |
Why?
|
| Endothelial Cells | 4 | 2017 | 296 | 0.930 |
Why?
|
| Niclosamide | 3 | 2023 | 8 | 0.930 |
Why?
|
| Retinal Pigment Epithelium | 5 | 2017 | 30 | 0.910 |
Why?
|
| Neuroblastoma | 1 | 2023 | 128 | 0.890 |
Why?
|
| Cattle | 21 | 2015 | 472 | 0.880 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 119 | 0.860 |
Why?
|
| Acrolein | 2 | 2012 | 15 | 0.840 |
Why?
|
| Vision, Ocular | 4 | 2014 | 40 | 0.830 |
Why?
|
| Retinal Vessels | 5 | 2016 | 24 | 0.810 |
Why?
|
| Glioblastoma | 2 | 2022 | 49 | 0.800 |
Why?
|
| Animals | 64 | 2020 | 14307 | 0.790 |
Why?
|
| Neuroprotective Agents | 1 | 2023 | 231 | 0.780 |
Why?
|
| Brain Neoplasms | 2 | 2022 | 105 | 0.770 |
Why?
|
| Retinol O-Fatty-Acyltransferase | 2 | 2012 | 2 | 0.740 |
Why?
|
| Zinc | 3 | 2021 | 114 | 0.730 |
Why?
|
| Cells, Cultured | 10 | 2018 | 1442 | 0.690 |
Why?
|
| Retinal Diseases | 1 | 2018 | 17 | 0.660 |
Why?
|
| Serpins | 3 | 2014 | 26 | 0.660 |
Why?
|
| Nerve Growth Factors | 3 | 2014 | 33 | 0.660 |
Why?
|
| Visual Acuity | 1 | 2018 | 98 | 0.640 |
Why?
|
| Glucose | 3 | 2008 | 217 | 0.630 |
Why?
|
| Cell Survival | 8 | 2020 | 818 | 0.630 |
Why?
|
| Ubiquitination | 1 | 2017 | 54 | 0.620 |
Why?
|
| Refractometry | 3 | 2006 | 14 | 0.610 |
Why?
|
| Light | 13 | 2015 | 180 | 0.610 |
Why?
|
| Ginsenosides | 1 | 2017 | 4 | 0.600 |
Why?
|
| Apoptosis | 5 | 2023 | 1317 | 0.600 |
Why?
|
| Carbonic Anhydrase II | 1 | 2016 | 2 | 0.580 |
Why?
|
| Acetazolamide | 1 | 2016 | 5 | 0.580 |
Why?
|
| Cell Proliferation | 6 | 2020 | 1149 | 0.560 |
Why?
|
| Neuroglia | 2 | 2017 | 117 | 0.550 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 91 | 0.550 |
Why?
|
| Radiation-Protective Agents | 1 | 2015 | 13 | 0.530 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 117 | 0.520 |
Why?
|
| Macrophages | 2 | 2016 | 431 | 0.510 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 756 | 0.500 |
Why?
|
| Eye | 5 | 2018 | 68 | 0.500 |
Why?
|
| Chromatography, High Pressure Liquid | 18 | 2014 | 406 | 0.500 |
Why?
|
| Estradiol | 2 | 2012 | 244 | 0.470 |
Why?
|
| Humans | 30 | 2023 | 34853 | 0.460 |
Why?
|
| Cytokines | 1 | 2017 | 569 | 0.460 |
Why?
|
| Cell Line | 6 | 2015 | 1289 | 0.440 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2012 | 3 | 0.440 |
Why?
|
| Signal Transduction | 6 | 2020 | 1802 | 0.440 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 122 | 0.420 |
Why?
|
| Goldfish | 10 | 1989 | 16 | 0.420 |
Why?
|
| Hyperglycemia | 1 | 2012 | 53 | 0.410 |
Why?
|
| Hydroxylamines | 1 | 2011 | 4 | 0.400 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2011 | 28 | 0.400 |
Why?
|
| Adaptation, Ocular | 4 | 2006 | 11 | 0.390 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 56 | 0.390 |
Why?
|
| Tamoxifen | 1 | 2011 | 61 | 0.390 |
Why?
|
| Structure-Activity Relationship | 4 | 2023 | 376 | 0.370 |
Why?
|
| Cyprinidae | 6 | 1989 | 9 | 0.370 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 445 | 0.360 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 2 | 2020 | 4 | 0.360 |
Why?
|
| Acyltransferases | 2 | 2009 | 21 | 0.360 |
Why?
|
| Epidermis | 2 | 2020 | 26 | 0.350 |
Why?
|
| Lens, Crystalline | 1 | 2009 | 14 | 0.350 |
Why?
|
| Cornea | 1 | 2009 | 55 | 0.350 |
Why?
|
| Macaca mulatta | 3 | 2015 | 122 | 0.330 |
Why?
|
| Blotting, Western | 4 | 2016 | 834 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 162 | 0.310 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 2128 | 0.310 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 430 | 0.310 |
Why?
|
| Rhodopsin | 10 | 1989 | 36 | 0.310 |
Why?
|
| Cell Count | 4 | 2014 | 129 | 0.300 |
Why?
|
| Vitreous Body | 1 | 2006 | 11 | 0.300 |
Why?
|
| Models, Biological | 3 | 2020 | 642 | 0.300 |
Why?
|
| Ultraviolet Rays | 2 | 2018 | 116 | 0.300 |
Why?
|
| Aqueous Humor | 1 | 2006 | 18 | 0.300 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2006 | 22 | 0.290 |
Why?
|
| Kinetics | 8 | 2016 | 650 | 0.280 |
Why?
|
| Scattering, Radiation | 4 | 2012 | 45 | 0.280 |
Why?
|
| Diterpenes | 14 | 2003 | 83 | 0.280 |
Why?
|
| Pineal Gland | 4 | 1993 | 30 | 0.260 |
Why?
|
| Choroid | 1 | 2004 | 10 | 0.250 |
Why?
|
| Epithelial Cells | 1 | 2006 | 366 | 0.230 |
Why?
|
| Models, Chemical | 1 | 2004 | 201 | 0.220 |
Why?
|
| Time Factors | 7 | 2012 | 1681 | 0.220 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2000 | 11 | 0.220 |
Why?
|
| RNA, Messenger | 3 | 2018 | 1152 | 0.210 |
Why?
|
| Esters | 4 | 2012 | 28 | 0.210 |
Why?
|
| Lipoylation | 1 | 2021 | 13 | 0.210 |
Why?
|
| Chelating Agents | 1 | 2021 | 53 | 0.200 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 968 | 0.190 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2020 | 5 | 0.190 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2020 | 4 | 0.190 |
Why?
|
| Isomerism | 6 | 2006 | 62 | 0.190 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2020 | 16 | 0.190 |
Why?
|
| Papilloma | 1 | 2020 | 15 | 0.190 |
Why?
|
| Nanoparticles | 2 | 2016 | 294 | 0.190 |
Why?
|
| src-Family Kinases | 1 | 2020 | 42 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 984 | 0.190 |
Why?
|
| Photoreceptor Cells | 6 | 1987 | 33 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 160 | 0.180 |
Why?
|
| Rats | 8 | 2014 | 3261 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 1530 | 0.170 |
Why?
|
| Retinal Neovascularization | 2 | 2011 | 9 | 0.170 |
Why?
|
| Photolysis | 2 | 2016 | 25 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 106 | 0.170 |
Why?
|
| Liver | 7 | 2003 | 447 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2018 | 31 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 176 | 0.160 |
Why?
|
| Placental Lactogen | 1 | 2018 | 8 | 0.160 |
Why?
|
| Awards and Prizes | 1 | 2018 | 27 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 151 | 0.160 |
Why?
|
| Growth Hormone | 1 | 2018 | 31 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 203 | 0.160 |
Why?
|
| Lasers | 2 | 2009 | 62 | 0.160 |
Why?
|
| Monte Carlo Method | 2 | 2009 | 55 | 0.160 |
Why?
|
| Cadaverine | 1 | 2017 | 4 | 0.160 |
Why?
|
| Gene Deletion | 1 | 2018 | 156 | 0.160 |
Why?
|
| Progesterone | 2 | 2009 | 117 | 0.160 |
Why?
|
| Anthelmintics | 1 | 2017 | 16 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 107 | 0.150 |
Why?
|
| Choroidal Neovascularization | 1 | 2017 | 4 | 0.150 |
Why?
|
| Autocrine Communication | 1 | 2017 | 10 | 0.150 |
Why?
|
| Paracrine Communication | 1 | 2017 | 14 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 122 | 0.150 |
Why?
|
| Arterioles | 1 | 2016 | 18 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 80 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2012 | 347 | 0.150 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 21 | 0.150 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 69 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2016 | 116 | 0.140 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1995 | 8 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2018 | 897 | 0.140 |
Why?
|
| Substrate Specificity | 5 | 2000 | 186 | 0.140 |
Why?
|
| Thermodynamics | 1 | 2016 | 207 | 0.130 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 37 | 0.130 |
Why?
|
| Culture Media, Serum-Free | 1 | 2014 | 40 | 0.130 |
Why?
|
| Ethylmaleimide | 2 | 2009 | 8 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 781 | 0.130 |
Why?
|
| Trout | 3 | 1979 | 4 | 0.130 |
Why?
|
| Salmonidae | 3 | 1979 | 4 | 0.130 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 1993 | 24 | 0.120 |
Why?
|
| Sulfhydryl Compounds | 1 | 2014 | 46 | 0.120 |
Why?
|
| Osmolar Concentration | 2 | 2011 | 55 | 0.120 |
Why?
|
| Optical Phenomena | 2 | 2013 | 21 | 0.120 |
Why?
|
| Circadian Rhythm | 2 | 1993 | 212 | 0.120 |
Why?
|
| Protein Binding | 1 | 2016 | 913 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2013 | 19 | 0.110 |
Why?
|
| Blood | 1 | 2013 | 32 | 0.110 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 20 | 0.110 |
Why?
|
| Melatonin | 1 | 1993 | 78 | 0.110 |
Why?
|
| Estrogen Receptor beta | 1 | 2012 | 37 | 0.110 |
Why?
|
| Models, Molecular | 1 | 2016 | 751 | 0.110 |
Why?
|
| Rod Cell Outer Segment | 4 | 1987 | 8 | 0.110 |
Why?
|
| Silver | 1 | 2012 | 53 | 0.110 |
Why?
|
| Bile Acids and Salts | 1 | 1992 | 31 | 0.110 |
Why?
|
| RNA | 1 | 2014 | 234 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2011 | 5 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2003 | 58 | 0.100 |
Why?
|
| Estrogen Antagonists | 1 | 2011 | 26 | 0.100 |
Why?
|
| Spectrophotometry | 5 | 2013 | 71 | 0.100 |
Why?
|
| Hydrolysis | 4 | 2000 | 86 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2011 | 31 | 0.100 |
Why?
|
| Isoquinolines | 1 | 2011 | 40 | 0.100 |
Why?
|
| Mice | 4 | 2020 | 5668 | 0.100 |
Why?
|
| Pyrroles | 1 | 2011 | 54 | 0.100 |
Why?
|
| Papio | 1 | 1990 | 21 | 0.100 |
Why?
|
| Temperature | 6 | 1989 | 275 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 386 | 0.090 |
Why?
|
| Pyridines | 1 | 2011 | 113 | 0.090 |
Why?
|
| Metal Nanoparticles | 1 | 2013 | 180 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1300 | 0.090 |
Why?
|
| Fatty Acids | 3 | 2000 | 118 | 0.090 |
Why?
|
| Estrogens | 1 | 2011 | 190 | 0.090 |
Why?
|
| Dark Adaptation | 3 | 2006 | 15 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 592 | 0.090 |
Why?
|
| DNA Primers | 1 | 2009 | 269 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2011 | 490 | 0.080 |
Why?
|
| Gerbillinae | 1 | 1987 | 2 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 605 | 0.080 |
Why?
|
| Base Sequence | 1 | 2009 | 932 | 0.080 |
Why?
|
| Hot Temperature | 1 | 1988 | 120 | 0.080 |
Why?
|
| Electrophysiology | 1 | 2007 | 130 | 0.080 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2006 | 2 | 0.070 |
Why?
|
| Body Fluids | 1 | 1986 | 15 | 0.070 |
Why?
|
| Protein Deficiency | 1 | 1986 | 1 | 0.070 |
Why?
|
| Stereoisomerism | 3 | 1992 | 162 | 0.070 |
Why?
|
| Dactinomycin | 1 | 2006 | 12 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Culture Media | 1 | 2006 | 84 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 1986 | 63 | 0.070 |
Why?
|
| Retinal Detachment | 1 | 1986 | 2 | 0.070 |
Why?
|
| Cycloheximide | 1 | 2006 | 30 | 0.070 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2014 | 196 | 0.070 |
Why?
|
| Equipment Design | 1 | 2006 | 127 | 0.070 |
Why?
|
| Lighting | 1 | 2006 | 11 | 0.070 |
Why?
|
| Tretinoin | 1 | 2006 | 50 | 0.070 |
Why?
|
| Male | 8 | 2020 | 18870 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2020 | 878 | 0.070 |
Why?
|
| Photic Stimulation | 1 | 2006 | 109 | 0.070 |
Why?
|
| Anisotropy | 1 | 2004 | 24 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2006 | 562 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2018 | 123 | 0.060 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2022 | 8 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 555 | 0.050 |
Why?
|
| Camptothecin | 1 | 2022 | 20 | 0.050 |
Why?
|
| Aged | 2 | 2020 | 6448 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2021 | 85 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2005 | 486 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 901 | 0.050 |
Why?
|
| Rana pipiens | 4 | 1989 | 58 | 0.050 |
Why?
|
| Isotretinoin | 1 | 2000 | 4 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 200 | 0.050 |
Why?
|
| Catalysis | 1 | 2000 | 162 | 0.040 |
Why?
|
| Darkness | 2 | 1991 | 27 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 247 | 0.040 |
Why?
|
| Rana catesbeiana | 3 | 1985 | 27 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2000 | 140 | 0.040 |
Why?
|
| Carboxylesterase | 1 | 1998 | 4 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1998 | 22 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 2000 | 66 | 0.040 |
Why?
|
| 5'-Nucleotidase | 1 | 1998 | 7 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 27 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 1998 | 48 | 0.040 |
Why?
|
| Papio hamadryas | 1 | 2018 | 3 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 72 | 0.040 |
Why?
|
| Palmitates | 1 | 1998 | 13 | 0.040 |
Why?
|
| Plants, Edible | 1 | 1998 | 2 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 2018 | 12 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2018 | 35 | 0.040 |
Why?
|
| Starvation | 1 | 1998 | 10 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1998 | 103 | 0.040 |
Why?
|
| Tyrosine | 1 | 2018 | 109 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2018 | 65 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 2018 | 59 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 608 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 580 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 1998 | 101 | 0.040 |
Why?
|
| Triolein | 1 | 1996 | 2 | 0.040 |
Why?
|
| Thulium | 1 | 2016 | 1 | 0.040 |
Why?
|
| beta Carotene | 1 | 1996 | 11 | 0.040 |
Why?
|
| Photochemistry | 1 | 2016 | 61 | 0.040 |
Why?
|
| Female | 5 | 2020 | 19873 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 80 | 0.040 |
Why?
|
| Surface Properties | 1 | 2016 | 121 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2016 | 197 | 0.040 |
Why?
|
| Cell Membrane | 1 | 1998 | 360 | 0.040 |
Why?
|
| Vitamin E | 1 | 1996 | 56 | 0.030 |
Why?
|
| Pregnancy | 2 | 2018 | 1503 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 1996 | 57 | 0.030 |
Why?
|
| Adult | 3 | 2006 | 11034 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1996 | 87 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 182 | 0.030 |
Why?
|
| Metmyoglobin | 1 | 2014 | 1 | 0.030 |
Why?
|
| Sulfonic Acids | 1 | 2014 | 3 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2014 | 25 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2014 | 46 | 0.030 |
Why?
|
| Benzothiazoles | 1 | 2014 | 20 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2333 | 0.030 |
Why?
|
| Acetylserotonin O-Methyltransferase | 1 | 1993 | 2 | 0.030 |
Why?
|
| Larva | 2 | 1985 | 117 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 64 | 0.030 |
Why?
|
| Crystallization | 1 | 2014 | 82 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 65 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2014 | 237 | 0.030 |
Why?
|
| Neodymium | 1 | 2013 | 3 | 0.030 |
Why?
|
| Yttrium | 1 | 2013 | 3 | 0.030 |
Why?
|
| Crotalid Venoms | 1 | 1993 | 1 | 0.030 |
Why?
|
| Plasma | 1 | 2013 | 29 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2013 | 24 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 30 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1993 | 52 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 1990 | 51 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 407 | 0.030 |
Why?
|
| Microsomes | 1 | 1992 | 52 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 173 | 0.030 |
Why?
|
| Rats, Inbred BB | 2 | 2003 | 2 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 859 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 1991 | 106 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 9642 | 0.020 |
Why?
|
| Ca(2+) Mg(2+)-ATPase | 1 | 1990 | 5 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1990 | 11 | 0.020 |
Why?
|
| Cell Separation | 1 | 1990 | 91 | 0.020 |
Why?
|
| Muscles | 2 | 1989 | 64 | 0.020 |
Why?
|
| Rabbits | 2 | 1986 | 278 | 0.020 |
Why?
|
| Biological Availability | 2 | 2000 | 84 | 0.020 |
Why?
|
| Glucosides | 1 | 1987 | 15 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1988 | 94 | 0.020 |
Why?
|
| Hydrolases | 1 | 1987 | 14 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1987 | 138 | 0.020 |
Why?
|
| Dehydroascorbic Acid | 1 | 1986 | 3 | 0.020 |
Why?
|
| Lysosomes | 1 | 1987 | 80 | 0.020 |
Why?
|
| Esterification | 1 | 1986 | 6 | 0.020 |
Why?
|
| Glycoside Hydrolases | 1 | 1986 | 6 | 0.020 |
Why?
|
| Indolizines | 1 | 1986 | 4 | 0.020 |
Why?
|
| Tunicamycin | 1 | 1986 | 23 | 0.020 |
Why?
|
| Ranidae | 1 | 1986 | 10 | 0.020 |
Why?
|
| Alkaloids | 1 | 1986 | 38 | 0.020 |
Why?
|
| Absorption | 1 | 2005 | 22 | 0.020 |
Why?
|
| Helminths | 1 | 1985 | 1 | 0.020 |
Why?
|
| Parasitic Diseases | 1 | 1985 | 6 | 0.020 |
Why?
|
| Lipids | 2 | 1998 | 222 | 0.020 |
Why?
|
| Eukaryota | 1 | 1985 | 20 | 0.020 |
Why?
|
| Reference Values | 1 | 2005 | 204 | 0.020 |
Why?
|
| Feces | 1 | 1985 | 110 | 0.020 |
Why?
|
| Jejunum | 1 | 2003 | 8 | 0.010 |
Why?
|
| Ileum | 1 | 2003 | 15 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 2003 | 19 | 0.010 |
Why?
|
| Infant | 1 | 1986 | 1014 | 0.010 |
Why?
|
| Triglycerides | 1 | 2003 | 129 | 0.010 |
Why?
|
| Brain | 2 | 1989 | 1268 | 0.010 |
Why?
|
| Detergents | 1 | 1982 | 23 | 0.010 |
Why?
|
| Surface-Active Agents | 1 | 1982 | 41 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 194 | 0.010 |
Why?
|
| Adolescent | 2 | 1996 | 5035 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2003 | 333 | 0.010 |
Why?
|
| Anura | 1 | 1980 | 29 | 0.010 |
Why?
|
| Thyroxine | 1 | 1979 | 17 | 0.010 |
Why?
|
| Homeostasis | 1 | 2000 | 172 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2000 | 196 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2000 | 287 | 0.010 |
Why?
|
| Niger | 1 | 1998 | 2 | 0.010 |
Why?
|
| Nutritive Value | 1 | 1998 | 28 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1978 | 51 | 0.010 |
Why?
|
| Minerals | 1 | 1998 | 45 | 0.010 |
Why?
|
| Carotenoids | 1 | 1998 | 70 | 0.010 |
Why?
|
| Amino Acids | 1 | 1998 | 139 | 0.010 |
Why?
|
| Seasons | 1 | 1977 | 112 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1996 | 10 | 0.010 |
Why?
|
| Eclampsia | 1 | 1996 | 10 | 0.010 |
Why?
|
| Nigeria | 1 | 1996 | 74 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1996 | 202 | 0.010 |
Why?
|
| Potentiometry | 1 | 1993 | 6 | 0.010 |
Why?
|
| Microchemistry | 1 | 1993 | 10 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1993 | 57 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1993 | 105 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1992 | 2 | 0.010 |
Why?
|
| Antibodies | 1 | 1993 | 135 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1996 | 613 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1992 | 24 | 0.010 |
Why?
|
| Biosensing Techniques | 1 | 1993 | 81 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 282 | 0.010 |
Why?
|
| Calmodulin | 1 | 1990 | 41 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1990 | 180 | 0.010 |
Why?
|
| alpha-Mannosidase | 1 | 1987 | 1 | 0.000 |
Why?
|
| Mannosidases | 1 | 1987 | 2 | 0.000 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 1987 | 3 | 0.000 |
Why?
|
| Acid Phosphatase | 1 | 1987 | 19 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1987 | 132 | 0.000 |
Why?
|
| beta-Galactosidase | 1 | 1987 | 34 | 0.000 |
Why?
|
| Swainsonine | 1 | 1986 | 2 | 0.000 |
Why?
|
| Parasite Egg Count | 1 | 1985 | 4 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1985 | 9 | 0.000 |
Why?
|
| Membranes | 1 | 1985 | 18 | 0.000 |
Why?
|
| Formaldehyde | 1 | 1985 | 33 | 0.000 |
Why?
|
| Acetates | 1 | 1985 | 20 | 0.000 |
Why?
|
| Cytosol | 1 | 1985 | 85 | 0.000 |
Why?
|
| Solubility | 1 | 1982 | 115 | 0.000 |
Why?
|
| Drug Stability | 1 | 1982 | 110 | 0.000 |
Why?
|
| Species Specificity | 1 | 1982 | 233 | 0.000 |
Why?
|